First liquid biopsy to receive FDA Approval for comprehensive ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SINGAPORE, Aug. 8, 2020 /PRNewswire-AsiaNet/-- The U.S. Food and Drug Administration (FDA) has approved Guardant Health's liquid biopsy, Guardant360(R) CDx, for tumor mutation profiling in patients across all solid cancers. Logo-https://photos.prnasia.com/prnh/20200530/2817723-1LOGOLOGO
...
Authors: LATEST ASIANET NEWS RELEASES